# Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies

> **NCT00389480** · PHASE1 · COMPLETED · sponsor: **Arno Therapeutics** · enrollment: 26 (actual)

## Conditions studied

- Tumors

## Interventions

- **DRUG:** AR-67 (formerly DB-67)

## Key facts

- **NCT ID:** NCT00389480
- **Lead sponsor:** Arno Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2009-02
- **Final completion:** 2009-05
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2009-08-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389480, "Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00389480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*